Fact CheckerSign in

NCT07247279Recruiting

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

A Multicenter Non Interventional Single Arm Retrospective-prospective Observational Study in Therapeutic Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis (gMG) in Real Clinical Practice in Russia

Source: ClinicalTrials.gov · Last updated 14 Oct 2026

Brief summary (registry, in English)

This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describe real-world treatment approaches and clinical outcomes among adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) in routine clinical practice in Russia.

Status (registry)
Recruiting
Study type
Observational
Enrollment
450 (estimated)
First submitted
18 Nov 2025
Start date
Dec 2025
Primary completion date
Dec 2029
Lead sponsor
AstraZeneca
NCT number
NCT07247279

What you commit to

  • Study type: Observational
  • Planned participants: 450
  • From Dec 2025 to the primary completion date, Dec 2029
  • 7 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participants currently enrolled in clinical studies for treatment of gMG.
  • Ocular MG only.

Who the study is looking for

  • Adults (≥18 years) diagnosed with generalized MG positive for acetylcholine receptor (AChR) antibodies.
  • Provision of signed and dated written informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (7)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
-
Coordinator of this site? Confirm its status
Kazan'RussiaRecruiting
-
Coordinator of this site? Confirm its status
MoscowRussiaRecruiting
-
Coordinator of this site? Confirm its status
NovosibirskRussiaRecruiting
-
Coordinator of this site? Confirm its status
Rostov-on-DonRussiaRecruiting
-
Coordinator of this site? Confirm its status
Saint PetersburgRussiaRecruiting
-
Coordinator of this site? Confirm its status
SamaraRussiaRecruiting
-
Coordinator of this site? Confirm its status
UfaRussiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.